Recovery Research Institute

Interest in cannabidiol (CBD) as a tool to reduce alcohol use is growing, however, a research study did not find evidence that it helped. Participants improved equally in both the CBD and placebo groups, suggesting that CBD is unlikely to help. Given the study small sample size, further study is needed.

Learn more here: https://www.recoveryanswers.org/research-post/does-cannabidiol-cbd-reduce-alcohol-use/

A hybrid treatment model, combining one in-person visit with telemedicine follow-up, retains people as well as standard in-person care when starting buprenorphine/naloxone for opioid use disorder.

Notably, withdrawal symptoms dropped by about 70% within the first week in both groups, highlighting how quickly this medication can begin to improve symptoms regardless of delivery method.

Learn more here: https://www.recoveryanswers.org/research-post/is-telemedicine-appropriate-therapeutic-mode-starting-someone-buprenorphine/

Have you submitted your proposal for NCARS yet? Join leading researchers from across the field this September to share your work and connect with the recovery science community.

Submit here: https://redcap.link/2026NCARS

Young adults have the highest rates of substance use disorder but lowest rates of recovery. About 22% of young adults report having a substance use disorder but only 5% say they are in recovery. In contrast, adults ages 26+ are nearly twice as likely to report being in recovery.

Learn more here: https://www.recoveryanswers.org/research-post/sud-and-recovery-vary-considerably-across-demographic-groups/


UMass SPARC
Collaborative Hub for Emerging Adult Recovery Research